US · USPH
U.S. Physical Therapy, Inc.
- Sector
- Healthcare · Medical - Care Facilities
- Headquarters
- Houston, TX 77042
- Website
- usph.com
Price · as of 2025-12-31
$71.83
Market cap 1.26B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $75.27 | +4.79% |
| Intrinsic Value(DCF) | $45.37 | -36.84% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $23.64 | -67.09% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $16.40 | $37.11 | $5.10 | $5.28 | $35.15 |
| 2012 | $19.63 | $36.65 | $3.84 | $0.00 | $21.65 |
| 2013 | $27.63 | $40.89 | $3.33 | $0.00 | $13.42 |
| 2014 | $41.80 | $48.10 | $24.31 | $0.74 | $37.30 |
| 2015 | $44.41 | $52.70 | $12.73 | $0.00 | $29.41 |
| 2016 | $63.94 | $57.29 | $7.89 | $0.00 | $25.32 |
| 2017 | $77.29 | $64.26 | $36.31 | $0.00 | $41.83 |
| 2018 | $98.06 | $72.94 | $33.91 | $0.00 | $13.81 |
| 2019 | $95.35 | $80.08 | $1.39 | $0.00 | $31.02 |
| 2020 | $111.89 | $79.17 | $0.00 | $1.69 | $0.00 |
| 2021 | $87.51 | $91.89 | $0.00 | $0.00 | $52.61 |
| 2022 | $89.08 | $90.80 | $0.00 | $0.00 | $42.27 |
| 2023 | $100.57 | $70.84 | $2.98 | $0.00 | $17.71 |
| 2024 | $78.96 | $74.13 | $0.00 | $0.00 | $32.76 |
| 2025 | $83.03 | $75.27 | $26.83 | $0.00 | $23.64 |
AI valuation
Our deep-learning model estimates U.S. Physical Therapy, Inc.'s (USPH) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $75.27
- Current price
- $71.83
- AI upside
- +4.79%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$45.37
-36.84% upside
Graham-Dodd
—
— upside
Graham Formula
$23.64
-67.09% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| USPH | U.S. Physical Therapy, In… | $71.83 | 1.26B | +5% | -37% | — | -67% | 21.72 | 2.64 | 1.61 | 15.05 | — | -3.24 | 20.15% | 10.30% | 1.93% | 12.02% | 7.45% | 4.89% | 0.89 | 8.50 | 1.01 | 0.72 | 3.56 | -2283.00% | 1633.00% | -725.00% | 4.84% | 0.54 | 7.58% | 2.17% | 47.20% | 2.61% | 20.52 | 27.06 | 2.11 | 2.88 |
| AHCO | AdaptHealth Corp. | $9.15 | 1.24B | +239% | -53% | — | — | -19.73 | 0.86 | 0.40 | 2.75 | — | -1.18 | 17.52% | 5.74% | -2.18% | -4.27% | 7.18% | -1.50% | 0.12 | 1.76 | 1.02 | 0.67 | 0.16 | -18525.00% | -49.00% | -696.00% | 16.84% | 0.84 | 8.45% | 0.00% | 0.00% | 148.90% | 7.43 | 6.31 | 0.43 | 0.97 |
| ASTH | Astrana Health, Inc. | $20.33 | 1.02B | +100% | +292,397% | -54% | +135% | 28.06 | 1.97 | 0.69 | 11.15 | — | 7.99 | 13.34% | 4.39% | 2.12% | 7.53% | 7.20% | 4.36% | 0.66 | 2.70 | 1.75 | 1.68 | 1.29 | -3023.00% | 4672.00% | 1126.00% | 3.15% | 0.14 | 5.76% | 0.29% | 8.10% | 0.35% | 17.71 | 35.82 | 0.78 | 3.26 |
| CNMD | CONMED Corporation | $46.00 | 1.42B | +64% | -60% | -94% | -57% | 30.20 | 1.38 | 1.03 | 12.53 | — | -3.99 | 53.87% | 9.47% | 3.42% | 4.72% | 4.69% | 2.03% | 0.81 | 4.19 | 2.14 | 0.92 | 4.49 | -6455.00% | 518.00% | -195.00% | 10.62% | 0.54 | 8.22% | 1.74% | 52.60% | 7.88% | 17.02 | 14.68 | 1.61 | 1.97 |
| GDRX | GoodRx Holdings, Inc. | $1.87 | 635.85M | +1,396% | -39% | -10% | +8% | 30.91 | 1.25 | 0.97 | 3.10 | 29.70 | 6.35 | 92.77% | 10.98% | 10.37% | 3.73% | 14.18% | 1.79% | 0.10 | 2.05 | 2.61 | 2.02 | -1.10 | 10407.00% | 57.00% | -3234.00% | 9.94% | 0.55 | 12.45% | 0.00% | 0.00% | 65.21% | 6.53 | 7.43 | 0.72 | 0.29 |
| HCSG | Healthcare Services Group… | $21.77 | 1.53B | +60% | -59% | -54% | -44% | 27.23 | 3.15 | 0.88 | 21.88 | 51.55 | 3.80 | 13.03% | 2.64% | 3.21% | 11.69% | 11.87% | 7.28% | 0.05 | 30.72 | 3.38 | 3.16 | -2.09 | 5283.00% | 708.00% | 46875.00% | 8.65% | 0.85 | 39.11% | 0.00% | 0.00% | 8.04% | 29.44 | 10.27 | 0.78 | 6.81 |
| KMTS | KESTRA MEDICAL TECHNOLOGI… | $23.28 | 1.36B | +67% | +283% | — | — | -6.49 | 3.60 | 12.35 | -5.57 | -4.28 | 3.60 | 40.47% | -177.85% | -190.28% | 5732.26% | 132.69% | -66.62% | 0.22 | -13.75 | 6.72 | 6.47 | 1.97 | 15147.00% | 11505.00% | 1941.00% | -13.70% | -2.04 | 126.23% | 0.22% | -1.50% | 31.39% | -5.13 | -5.39 | 9.12 | 2.34 |
| NEOG | Neogen Corporation | $11.23 | 2.44B | +204% | -82% | — | — | -1.01 | 0.53 | 1.23 | -2.01 | -0.01 | -2.73 | 47.10% | 1.05% | -122.06% | -41.88% | 0.27% | -27.33% | 0.44 | 0.13 | 3.32 | 1.62 | -0.84 | 1146322.00% | -320.00% | -3914.00% | -4.21% | 0.33 | -1.38% | 0.00% | 0.00% | 0.00% | 200.15 | -40.68 | 2.11 | 0.67 |
| PNTG | The Pennant Group, Inc. | $33.71 | 1.17B | -6% | +3,232% | -79% | +9% | 39.52 | 3.51 | 1.23 | 26.38 | 215.84 | -11.23 | 12.92% | 5.42% | 3.12% | 9.45% | 5.80% | 3.59% | 1.36 | 7.70 | 1.14 | 0.95 | 7.17 | 1831.00% | 3631.00% | 5935.00% | 4.13% | 0.33 | 7.37% | 0.00% | 0.00% | 0.00% | 31.23 | 33.24 | 1.69 | 2.49 |
| SEM | Select Medical Holdings C… | $14.97 | 1.86B | +47% | -60% | — | +4% | 12.67 | 1.09 | 0.34 | 10.42 | — | -2.45 | 11.54% | 6.14% | 2.68% | 8.63% | 5.42% | 2.55% | 2.17 | 2.85 | 1.04 | 0.90 | 6.93 | -2892.00% | 512.00% | -2908.00% | 20.66% | 0.35 | 7.88% | 1.70% | 21.50% | 7.10% | 16.53 | 14.45 | 1.01 | 1.62 |
| ZBIO | Zenas BioPharma, Inc. | $26.35 | 1.1B | -12% | -81% | — | +1,012% | -1.98 | 1.00 | 62.26 | 0.23 | -0.69 | 1.00 | -2682.78% | -3277.76% | -3139.76% | -361.99% | 109.71% | -71.66% | 0.00 | — | 6.21 | 6.12 | 1.95 | 28763.00% | -9000.00% | 29221.00% | -38.49% | -2.09 | 80.20% | 0.00% | 0.00% | 90.91% | 0.23 | 0.32 | -7.69 | 1.30 |
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
- CEO
- Christopher J. Reading
- Employees
- 4.03K
- Beta
- 1.30
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($45.37 ÷ $71.83) − 1 = -36.84% (DCF, example).